January 26, 2017

O2 RegenTech Receives $600,000 to Develop Oxygenating Wound Treatments

O2 RegenTech, a medical technology company focused on wound care solutions, has been awarded a total of $600,000 from the National Science Foundation Small Business Innovation Research grant, the National Institutes of Health Small Business Technology Transfer grant, and Ohio Third Frontier Technology Validation and Startup Fund. Funds will be used to conduct research and development on its oxygenating wound dressing that enhances chronic wound healing.